Highbridge Capital Management’s Cartesian Growth Corp II RENE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,498,671
Closed -$15.4M 473
2022
Q4
$15.4M Sell
1,498,671
-569,271
-28% -$5.77M 0.42% 82
2022
Q3
$20.7M Buy
+2,067,942
New +$20.7M 0.29% 51

Other funds holding RENE

Highbridge Capital Management's RENE Position: Q1 2023 in Review

Highbridge Capital Management sold out of Cartesian Growth Corp II (RENE) in Q1 2023, closing a stake of 1,498,671 shares — an estimated $15.4M sold.

Highbridge Capital Management first reported a position in RENE in Q3 2022 and held it in 2 quarters. The position peaked at $20.7M in Q3 2022. 50 funds tracked by Wall St. Rank hold RENE as of Q1 2023.

  • Highbridge Capital Management reported no remaining Cartesian Growth Corp II position as of Q1 2023 after selling out during the quarter.
  • Highbridge Capital Management sold 1,498,671 Cartesian Growth Corp II shares in Q1 2023, an estimated $15.4M.
  • Highbridge Capital Management first reported a position in Cartesian Growth Corp II in Q3 2022 and held it in 2 quarters.
  • Highbridge Capital Management's Cartesian Growth Corp II position peaked at $20.7M in Q3 2022.
  • 50 funds tracked by Wall St. Rank held Cartesian Growth Corp II as of Q1 2023.

Based on Highbridge Capital Management's 13F filing for Q1 2023, filed 11 May 2023.